ReviewEuropean geriatric medicine2026
Effects of different exercise types and intensities in older adults with sarcopenia: a systematic review and network meta-analysis.
Review in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveExercise is an important non-pharmacological strategy for the management of sarcopenia. However, the relative effects of different exercise modalities and dose parameters remain unclear.
methodsWe conducted a systematic review and network meta-analysis of randomized controlled trials. The analysis comprehensively evaluated the effects of different exercise interventions and prescription parameters on sarcopenia-related outcomes.
resultsNineteen randomized controlled trials involving 1,267 participants were included. Compared with routine control, moderate-intensity resistance training (MRT) showed the clearest improvement in handgrip strength (mean difference [MD] = 2.37, 95% confidence interval [CI] 0.76-3.98). It also ranked highly for skeletal muscle mass index (SMI) and gait speed, but the related evidence remained uncertain. The findings for SMI were affected by local inconsistency. For gait speed, no intervention showed a significant advantage over routine control. Exploratory analyses suggested that training intensity, frequency, and intervention duration may jointly shape treatment responses across different outcomes.
conclusionsMRT may be considered a reasonable option for improving handgrip strength in older adults with sarcopenia. However, the current evidence does not support identifying a single best exercise approach across all outcomes. Exercise prescription for sarcopenia should therefore be guided by the target outcome and clinical relevance. REGISTRATION NUMBER: CRD42024603850.
Indexed as
Identifiers
42560629What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.